PL3865137T3 - Kompozycje i ich zastosowanie w leczeniu lub zapobieganiu niewydolności żylnej - Google Patents

Kompozycje i ich zastosowanie w leczeniu lub zapobieganiu niewydolności żylnej

Info

Publication number
PL3865137T3
PL3865137T3 PL21157648.3T PL21157648T PL3865137T3 PL 3865137 T3 PL3865137 T3 PL 3865137T3 PL 21157648 T PL21157648 T PL 21157648T PL 3865137 T3 PL3865137 T3 PL 3865137T3
Authority
PL
Poland
Prior art keywords
treatement
prevention
compositions
venous insufficiency
insufficiency
Prior art date
Application number
PL21157648.3T
Other languages
English (en)
Inventor
Angelo Pizzoni
Paolo PIZZONI
Original Assignee
Italfarmaco S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco S.P.A. filed Critical Italfarmaco S.P.A.
Publication of PL3865137T3 publication Critical patent/PL3865137T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL21157648.3T 2020-02-17 2021-02-17 Kompozycje i ich zastosowanie w leczeniu lub zapobieganiu niewydolności żylnej PL3865137T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102020000003122A IT202000003122A1 (it) 2020-02-17 2020-02-17 Associazione di principi attivi e loro uso nel trattamento e/o nella prevenzione della insufficienza venosa

Publications (1)

Publication Number Publication Date
PL3865137T3 true PL3865137T3 (pl) 2025-10-27

Family

ID=70738838

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21157648.3T PL3865137T3 (pl) 2020-02-17 2021-02-17 Kompozycje i ich zastosowanie w leczeniu lub zapobieganiu niewydolności żylnej

Country Status (7)

Country Link
EP (1) EP3865137B1 (pl)
ES (1) ES3036471T3 (pl)
HR (1) HRP20251141T1 (pl)
IT (1) IT202000003122A1 (pl)
PL (1) PL3865137T3 (pl)
RS (1) RS67199B1 (pl)
SM (1) SMT202500294T1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20060802A1 (it) * 2006-04-21 2007-10-22 Infarma S R L Composizione erboristica a rilascio prolungato contenente estratti vegetali
EP2353596A1 (en) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
ITRM20120591A1 (it) * 2012-11-26 2014-05-27 Ambiotec Sas Di Ammendola Sergio Composizioni da utilizzare nelle flebopatologie da stasi ed infiammatorie

Also Published As

Publication number Publication date
SMT202500294T1 (it) 2025-09-12
RS67199B1 (sr) 2025-10-31
IT202000003122A1 (it) 2021-08-17
ES3036471T3 (en) 2025-09-19
EP3865137B1 (en) 2025-06-25
EP3865137C0 (en) 2025-06-25
HRP20251141T1 (hr) 2025-11-21
EP3865137A1 (en) 2021-08-18

Similar Documents

Publication Publication Date Title
IL281999A (en) YAP/TAZ-TEAD interaction inhibitors and their use in cancer therapy
IL307201A (en) Triazine derivatives and their use in cancer treatment.
IL286334A (en) Modified microRNAs and their use in cancer treatment
KR102217525B9 (ko) 치주염 예방 또는 치료용 유산균 및 그의 용도
ZA202307970B (en) Compounds for use in the treatment and prevention of covid- 19
IL289758B1 (en) Proportin inhibitors for use in the prevention and treatment of kidney injury
IT201700089258A1 (it) Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IL291388B1 (en) Heterocyclic derivatives, pharmaceutical preparations and their use for the treatment or alleviation of cancer
ZA202207728B (en) Compositions comprising amino acids for use in the prevention and treatment of chemotherapy side effects
IL312928A (en) Complement Factor B Modulating Preparations and Methods for Using Them
PL3865137T3 (pl) Kompozycje i ich zastosowanie w leczeniu lub zapobieganiu niewydolności żylnej
PL3541185T3 (pl) Zastosowanie 2-hydroksybenzyloaminy w leczeniu i zapobieganiu nadciśnieniu płucnemu
PL3902548T3 (pl) Inhibitor egfr z powodującą oporność na leczenie mutacją l718 i/lub l792 do stosowania w leczeniu nowotworu
IL290192A (en) Nitanin analogs and their use in the treatment of chronic and acute pain
PL3937949T3 (pl) Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu upośledzenia funkcji oddechowych
PL3829553T3 (pl) Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego
PL4346847T3 (pl) Kompleks wielojonowy do stosowania w profilaktyce lub leczeniu zapalenia neurogennego
ZA201804198B (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
EP4043027A4 (en) APPLICATION OF PEG INTERFERON AND PROTO-ONCOGEN TARGETING INHIBITOR IN SYNERGISTIC TREATMENT OF RENAL CARCINOMA
IL268860A (en) Granzyme B inhibitor preparations and methods for preventing and/or treating blistered and/or peeling skin
KR102217518B9 (ko) 치주염 예방 또는 치료용 유산균 및 그의 용도
GB2610895C (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202108523D0 (en) Compositions and their use for the treatment of alpha1-antitrypsin deficiency
IL259395B (en) A cosmetic compound for use in the treatment and prevention of skin with acne
GB201914142D0 (en) Treatment and prevention of vascular calcification